Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Approximately 0.05% of consumers who purchased the CW FSHE products from January 2019 to July 2020 reported an adverse event. The percentage of AEs and SAEs per products sold was 0.02% and 0.0004%, respectively. These data demonstrate that CW FSHE products appear to be well tolerated at recommended doses.
Authors
- Ivori Zvorsky (ORCID: https://orcid.org/0009-0007-9101-2371)
- Kevin Spelman (ORCID: https://orcid.org/0000-0002-4363-1748)
- Colleen M Kingsbury
Institutions
- Massachusetts College of Pharmacy and Health Sciences (US)
- Health Education England (GB)
- Buffalo Medical Group (US)
- Charlotte's Web (United States) (US)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1007/s40801-024-00454-x
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.35